Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Gastrointestinal 1

Conditions

Neutropenia 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Invasive Fungal Infections 1Infections 1Hematologic Neoplasms 1Carcinoma, Hepatocellular 1Candidiasis, Invasive 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Anidulafungin × Clear all
NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

Completed
40,110 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01249820 2020-12-08

ANIDULAPK

Radboud University Medical Center

Phase 2 Completed
26 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00068471 2013-06-19

Anidulafungin in Treating Immunocompromised Children With Neutropenia

National Cancer Institute (NCI)

Phase 1/2 Completed

Infections, Neutropenia

NCT01053884 2012-03-02

ECALTA

Elisabethinen Hospital

Phase 2 Terminated
10 enrolled
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms, Candidiasis, Invasive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡